The small variant of the apoptosis-associated X-chromosome RBM10 gene is co-expressed with caspase-3 in breast cancer

Cancer Genomics and Proteomics

Volumn 5, Issue 3-4, 2008, Pages 169-174

  Martin Garabato E ^a   Martinez Arribas F ^a,b   Pollan M ^c   Lucas, A R ^a   Sanchez J ^a,d   Schneider, J ^a,b  

^a Centro de Patología de la Mama Fundación Tejerina   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Apoptosis; Bax; Breast; Cancer; Caspase 3; CD105; RBM

Indexed keywords

CASPASE 3; ENDOGLIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AXILLA; BREAST CANCER; CD105 GENE; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; HISTOLOGY; HMAM GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MULTIGENE FAMILY; NUP88 GENE; PLOIDY; PROTEIN EXPRESSION; RBM10 GENE; RBM3 GENE; RBMX GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; VEGF GENE; X CHROMOSOME;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; RNA-BINDING PROTEINS;

EID: 46849092189     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Vakkala M, Lähteenmäki K, Raunio H, Pääkkö P and Soini Y: Apoptosis during breast carcinoma progression. Clin Cancer Res 5: 319-324, 1999.
2. Kumar R, Vadlamudi RK and Adam L: Apoptosis in mammary gland and cancer. Endocrine-rel Cancer 7: 257-269, 2000.
3. Reed JC: Balancing cell life and death: Bax, apoptosis, and breast cancer. J Clin Invest 97: 2403-2404, 1996.
4. Martinez-Arribas F, Alvarez T, Del Val G, Martin-Garabato E, Nuñez-Villar MJ, Lucas R, Sánchez J, Tejerina A and Schneider J: Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. Anticancer Res 27: 219-222, 2007.
5. Blanc C, Deveraux QL, Krajewski S, Jänicke RU, Porter AG, Reed JC, Jaggi R and Marti A: Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res 60: 4386-4390, 2000.
6. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ and Thor AD: Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res 61: 348-354, 2001.
7. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, Tora AD and Mehta K: Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21: 8843-8851, 2002.
8. Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J and Dowsett M: Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin Cancer Res 8: 2100-2108, 2002.
9. Martínez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R and Schneider J: Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem 97: 1275-1282, 2006.
10. Núñez-Villar MJ, Martínez-Arribas F, Pollán M, Lucas AR, Sánchez J, Tejerina A and Schneider J: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumor phenotype. Breast Cancer Res 5: R65-R70, 2003.
11. Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nuñez-Villar MJ, Pollan M and Schneider J: Nup88-mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 109: 717-20, 2004.
12. Gómez-Esquer F, Agudo D, Martínez-Arribas F, Núñez-Villar MJ, Pollán M and Schneider J: The X-chromosome RBMX gene is expressed in mammary carcinoma. Cancer Genomics Proteomics 1: 39-44, 2004.
13. Schneider J, Rubio MP, Rodríguez-Escudero FJ, Seizinger BS and Castresana JS: Identification of p53 mutations by means of SSCP (single strand conformation polymorphism) analysis in gynaecologic tumors: comparison with the results of imunohistochemistry. Eur J Cancer 30A: 504-508, 1994.
14. Schmitt FC, Soares R, Cirnes L and Seruca R: P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach. Pathol Res Pract 194: 815-819, 1998.
15. O'Donovan N, Crown J, Stunell H, Hill ADK, Mc Dermott E, O'Higgins N and Duffy MJ: Caspase 3 in breast cancer. Clin Cancer Res 9: 738-742, 2003.
16. Li C, Issa R, Hampson IN, López-Novoa J, Bernabeu C and Kumar S: CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116: 2677-2685, 2003.
17. Liang Y, Brekken RA and Hyden SM: Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferation activity of anti-hormones. Endocrrel Cancer 13: 905-919, 2006.
18. Akahane M, Akahane T, Matheny SL, Shah A, Okajima E and Thorgeirsson UP: Vascular endothelial growth factor D is a survival factor for human breast carcinoma cells. Int J Cancer 118: 841-849, 2006.